AnaptysBio Inc News - ANAB | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AnaptysBio Inc (ANAB)

13.89

-0.08

(-0.57%)

Closed 25 December 8:00AM

Delayed by 15 minutes

13.89

0.00

(0.00%)

After Hours: 9:00AM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Anaptys Announces Participation in September Investor Conferences

SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 144 - Report of proposed sale of securities

Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

SAN DIEGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update

Top-line data expected in December 2024 after having completed enrollment for Phase 2b trial to treat atopic...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
2
Next

Monksdream

Monksdream 3 months ago

ANAB definite uptrend

gfp927z

gfp927z 3 years ago

HighPeaks, The NY Times article was high profile, but the connection to ANAB isn't readily apparent.

Even with the partial sale/monetization of the revenue stream from dostarlimab in December, the drug is also being studied by Glaxo for other cancer types (endometrial, non-small cell lung, ovarian, and mismatch repair deficient solid tumors). One question to answer is whether the monetization deal with Sagard was only for colorectal, or for all the indications? Probably for all, but I'll have to do more research.

ANAB has numerous other programs and a large pile of cash, so looks interesting. But investing in biotech requires a ton of research, but even then you still don't know what you have, and landmines are everywhere. Better to invest in 'what you know', as Buffett recommends :o)

---

HighPeaks

HighPeaks 3 years ago

Thanks TP. Yeah this has the potential to really be a big mover. So surprised no one has made the connection between this potential miracle drug and $ANAB receiving royalties on it(as it’s originator). GSK is the collaborator who has just commercialized it but it’s ANAB invention.

tedpeele

tedpeele 3 years ago

Tremendous find HighPeaks. .You have been early on quite a few big movers. I'm thinking this is yet another one.

Will be watching this closely...thanks.

HighPeaks

HighPeaks 3 years ago

According to this link ANAB gets 8-25% royalties from Dostarlimab. This drug has recently shown phenomenal results in a trial at Memorial Sloan Kettering Hospital. All patients fully recovered from rectal cancer.
https://www.globenewswire.com/fr/news-release/2020/10/26/2114250/0/en/AnaptysBio-and-GlaxoSmithKline-Amend-Strategic-Immuno-Oncology-Collaboration.html

TFMG

TFMG 4 years ago

$ANAB | #Anaptysbio Spikes After Drug Designation

Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

LoveItInBishop

LoveItInBishop 5 years ago

RSI @ 16. laughable. Zacks has positive take. https://finance.yahoo.com/news/anaptysbio-enters-oversold-territory-135501475.html

ClayTrader

ClayTrader 5 years ago

* * $ANAB Video Chart 11-13-19 * *

Link to Video - click here to watch the technical chart video

ClayTrader

ClayTrader 5 years ago

* * $ANAB Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

waterchaser

waterchaser 5 years ago

LOL! Twitter PnD. Buyer beware.

420man

420man 5 years ago

Once the real bounce starts it will be fast....

Crazy Money

Crazy Money 5 years ago

420man

420man 5 years ago

This will bounce..... 15 AH

RJ Trotts

RJ Trotts 5 years ago

trying to bounce back over $11, hoping for more

TaxiCaT

TaxiCaT 5 years ago

celle

celle 6 years ago

Nothing happen here?

manny371

manny371 7 years ago

This stock is making noise! Bought in Sept $ANAB

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions